690 related articles for article (PubMed ID: 23266841)
21. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
[TBL] [Abstract][Full Text] [Related]
22. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
[TBL] [Abstract][Full Text] [Related]
23. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase.
Suzuki-Inoue K; Inoue O; Frampton J; Watson SP
Blood; 2003 Aug; 102(4):1367-73. PubMed ID: 12730118
[TBL] [Abstract][Full Text] [Related]
24. Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI.
Wijeyewickrema LC; Gardiner EE; Moroi M; Berndt MC; Andrews RK
Thromb Haemost; 2007 Dec; 98(6):1285-90. PubMed ID: 18064326
[TBL] [Abstract][Full Text] [Related]
25. Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI.
Inoue K; Ozaki Y; Satoh K; Wu Y; Yatomi Y; Shin Y; Morita T
Biochem Biophys Res Commun; 1999 Mar; 256(1):114-20. PubMed ID: 10066433
[TBL] [Abstract][Full Text] [Related]
26. The CEACAM1-derived peptide QLSN impairs collagen-induced human platelet activation through glycoprotein VI.
Ye Y; Wan W; Wang J; Hu W; Wang H; Li L; Sang P; Gu Y; Li D; Wang Z; Meng Z
Biosci Biotechnol Biochem; 2020 Jan; 84(1):85-94. PubMed ID: 31794329
[TBL] [Abstract][Full Text] [Related]
27. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
Francischetti IM; Ghazaleh FA; Reis RA; Carlini CR; Guimarães JA
Arch Biochem Biophys; 1998 May; 353(2):239-50. PubMed ID: 9606958
[TBL] [Abstract][Full Text] [Related]
28. Docking protein Gab2 positively regulates glycoprotein VI-mediated platelet activation.
Yi Q; Suzuki-Inoue K; Asazuma N; Inoue O; Watson SP; Ozaki Y
Biochem Biophys Res Commun; 2005 Nov; 337(2):446-51. PubMed ID: 16198316
[TBL] [Abstract][Full Text] [Related]
29. Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets.
Wonerow P; Obergfell A; Wilde JI; Bobe R; Asazuma N; Brdicka T; Leo A; Schraven B; Horejsí V; Shattil SJ; Watson SP
Biochem J; 2002 Jun; 364(Pt 3):755-65. PubMed ID: 12049640
[TBL] [Abstract][Full Text] [Related]
30. Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets.
Ezumi Y; Shindoh K; Tsuji M; Takayama H
J Exp Med; 1998 Jul; 188(2):267-76. PubMed ID: 9670039
[TBL] [Abstract][Full Text] [Related]
31. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.
Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-Marín F
Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020
[TBL] [Abstract][Full Text] [Related]
32. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W
Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962
[TBL] [Abstract][Full Text] [Related]
33. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
34. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
Front Immunol; 2021; 12():766272. PubMed ID: 34912339
[TBL] [Abstract][Full Text] [Related]
35. Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.
Whang JA; Chang BY
Drug Discov Today; 2014 Aug; 19(8):1200-4. PubMed ID: 24721226
[TBL] [Abstract][Full Text] [Related]
36. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets.
Spalton JC; Mori J; Pollitt AY; Hughes CE; Eble JA; Watson SP
J Thromb Haemost; 2009 Jul; 7(7):1192-9. PubMed ID: 19422460
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms.
Buitrago L; Bhavanasi D; Dangelmaier C; Manne BK; Badolia R; Borgognone A; Tsygankov AY; McKenzie SE; Kunapuli SP
J Biol Chem; 2013 Oct; 288(40):29160-9. PubMed ID: 23960082
[TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
39. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
[TBL] [Abstract][Full Text] [Related]
40. Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.
Wang SP; Iwata S; Nakayamada S; Niiro H; Jabbarzadeh-Tabrizi S; Kondo M; Kubo S; Yoshikawa M; Tanaka Y
Rheumatology (Oxford); 2015 Aug; 54(8):1488-97. PubMed ID: 25724205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]